A detailed history of High Tower Advisors, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 41,456 shares of ILMN stock, worth $5.93 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
41,456
Previous 39,496 4.96%
Holding current value
$5.93 Million
Previous $4.12 Million 31.13%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$105.28 - $135.9 $206,348 - $266,364
1,960 Added 4.96%
41,456 $5.41 Million
Q2 2024

Aug 13, 2024

SELL
$101.05 - $133.57 $535,767 - $708,188
-5,302 Reduced 11.84%
39,496 $4.12 Million
Q1 2024

May 06, 2024

BUY
$127.73 - $147.2 $537,360 - $619,270
4,207 Added 10.36%
44,798 $6.15 Million
Q4 2023

Feb 12, 2024

SELL
$92.79 - $142.53 $2.11 Million - $3.24 Million
-22,712 Reduced 35.88%
40,591 $5.65 Million
Q3 2023

Nov 08, 2023

BUY
$128.91 - $192.44 $213,732 - $319,065
1,658 Added 2.69%
63,303 $8.69 Million
Q2 2023

Aug 14, 2023

BUY
$183.43 - $232.67 $563,313 - $714,529
3,071 Added 5.24%
61,645 $11.6 Million
Q1 2023

May 11, 2023

BUY
$193.75 - $232.55 $150,931 - $181,156
779 Added 1.35%
58,574 $13.6 Million
Q4 2022

Feb 08, 2023

BUY
$187.24 - $242.74 $632,496 - $819,975
3,378 Added 6.21%
57,795 $11.7 Million
Q3 2022

Nov 09, 2022

SELL
$177.23 - $227.44 $516,093 - $662,305
-2,912 Reduced 5.08%
54,417 $10.4 Million
Q2 2022

Aug 10, 2022

BUY
$181.58 - $368.0 $521,860 - $1.06 Million
2,874 Added 5.28%
57,329 $10.6 Million
Q1 2022

May 12, 2022

BUY
$303.87 - $423.8 $1.68 Million - $2.34 Million
5,516 Added 11.27%
54,455 $19 Million
Q4 2021

Feb 10, 2022

BUY
$347.28 - $421.83 $3.58 Million - $4.35 Million
10,308 Added 26.68%
48,939 $18.6 Million
Q3 2021

Nov 12, 2021

BUY
$405.61 - $524.84 $1.14 Million - $1.48 Million
2,817 Added 7.87%
38,631 $15.7 Million
Q2 2021

Aug 06, 2021

BUY
$372.84 - $481.5 $656,198 - $847,440
1,760 Added 5.17%
35,814 $16.9 Million
Q1 2021

May 10, 2021

BUY
$361.28 - $504.76 $976,178 - $1.36 Million
2,702 Added 8.62%
34,054 $13.1 Million
Q4 2020

Feb 10, 2021

BUY
$292.7 - $370.96 $2.6 Million - $3.3 Million
8,885 Added 39.55%
31,352 $11.6 Million
Q3 2020

Nov 13, 2020

BUY
$268.51 - $400.74 $813,316 - $1.21 Million
3,029 Added 15.58%
22,467 $6.94 Million
Q2 2020

Aug 10, 2020

SELL
$256.46 - $373.01 $35,647 - $51,848
-139 Reduced 0.71%
19,438 $7.19 Million
Q1 2020

May 21, 2020

SELL
$209.2 - $335.53 $997,047 - $1.6 Million
-4,766 Reduced 19.58%
19,577 $5.34 Million
Q4 2019

Feb 14, 2020

BUY
$288.29 - $335.49 $462,128 - $537,790
1,603 Added 7.05%
24,343 $8.09 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $554,226 - $785,583
2,077 Added 10.05%
22,740 $6.91 Million
Q2 2019

Aug 13, 2019

SELL
$300.59 - $368.15 $752,977 - $922,215
-2,505 Reduced 10.81%
20,663 $7.6 Million
Q1 2019

May 15, 2019

BUY
$272.57 - $321.18 $1.6 Million - $1.88 Million
5,858 Added 33.84%
23,168 $7.19 Million
Q4 2018

Feb 14, 2019

BUY
$272.46 - $366.54 $1.19 Million - $1.6 Million
4,353 Added 33.6%
17,310 $5.18 Million
Q3 2018

Nov 09, 2018

SELL
$279.04 - $367.06 $84,549 - $111,219
-303 Reduced 2.29%
12,957 $4.76 Million
Q2 2018

Aug 14, 2018

BUY
$228.17 - $292.07 $260,798 - $333,836
1,143 Added 9.43%
13,260 $3.71 Million
Q1 2018

May 15, 2018

BUY
$209.54 - $253.91 $76,482 - $92,677
365 Added 3.11%
12,117 $2.87 Million
Q4 2017

Feb 14, 2018

BUY
$202.23 - $230.03 $15,976 - $18,172
79 Added 0.68%
11,752 $2.56 Million
Q3 2017

Nov 14, 2017

BUY
$172.3 - $213.93 $114,924 - $142,691
667 Added 6.06%
11,673 $2.33 Million
Q2 2017

Aug 14, 2017

BUY
N/A
11,006
11,006 $1.91 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $22.5B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.